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Introduction: Mesenchymal stem cells (MSCs) have therapeutic potential for the repair of myocardial injury. The
efficacy of MSC therapy for myocardial regeneration mainly depends on the survival of cells after transplantation
into the infarcted heart. In the transplanted regions, reactive oxygen species (ROS) can cause cell death, and this
process depends on caspase activation and autophagosome formation.
Methods: A Software TargetScan was utilized to search for microRNAs (miRNAs) that target caspase-3 mRNA. Six
candidate miRNAs including let-7b were selected and transfected into human MSCs in vitro. Expression of MEK-EKR
signal pathways and autophagy-related genes were detected. Using ischemia/reperfusion model (I/R), the effect of
MSCs enriched with let-7b was determined after transplantation into infarcted heart area. Miller catheter was used
to evaluate cardiac function.
Results: Here, we report that let-7b targets caspase-3 to regulate apoptosis and autophagy in MSCs exposed to
ROS. Let-7b-transfected MSCs (let-7b-MSCs) showed high expression of survival-related proteins, including p-MEK,
p-ERK and Bcl-2, leading to a decrease in Annexin V/PI- and TUNEL-positive cells under ROS-rich conditions.
Moreover, autophagy-related genes, including Atg5, Atg7, Atg12 and beclin-1, were significantly downregulated in
let-7b-MSCs. Using a rat model of acute myocardial infarction, we found that intramyocardial injection of let-7b-MSCs
markedly enhanced left ventricular (LV) function and microvessel density, in accordance with a reduced infarct size and
the expression of caspase-3.
Conclusions: Taken together, these data indicate that let-7b may protect MSCs implanted into infarcted myocardium
from apoptosis and autophagy by directly targeting caspase-3 signaling.Introduction
Despite continuous improvements in the prevention and
treatment of heart disease, ischemic heart disease is the
most common cause of mortality worldwide [1]. Ischemic
injury to the heart causes various types of cardiomyocyte* Correspondence: kchwang@cku.ac.kr
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treatment methods for ischemic heart disease have been
explored, including gene-based, growth factor-based, and
cell-based therapies [2]. Mesenchymal stem cells (MSCs)
are an attractive source for cell-based therapies and can
be used to repair bone [3], cartilage [4], and heart tissue
[5]. In fact, over the last decade, transplantation of MSCs
has been considered as a therapeutic method for repairing
the infarcted region of ischemic hearts [1]. However, the
low viability of cells after transplantation has hampered
therapeutic efficacy of cell therapy. Thus, identifying
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utilization of these cells in cell therapy.
Reactive oxygen species (ROS) play an important role
as an inducer of cell death pathways, including ap-
optosis, anoikis, and autophagy, in ischemic hearts [6].
Among these cell death pathways, apoptosis plays an im-
portant role in the elimination of unnecessary cells and
is induced by the orchestrated activity of caspase family
proteins [7]. Caspase family proteins play a critical role
in both the intrinsic and extrinsic apoptosis pathways.
During apoptosis, caspases initiate a two-step pathway
in which initiator caspases (caspase-8, caspase-9, and
caspase-10) cleave executioner caspases (caspase-3 and
caspase-7) to activate them [8]. Both caspase-8 and
caspase-9 activate caspase-3, which in turn cleaves sev-
eral crucial substrates including the DNA repair enzyme
poly(ADP-ribose) polymerase (PARP) [9]. Autophagy, or
self-digestion, is also activated in response to stressors
such as ischemia/reperfusion (I/R). Substrates, such as
aggregated proteins or damaged organelles, are engulfed
during autophagy to form autophagosomes [10, 11].
Although autophagy plays a protective role under a
physiologic condition by degrading damaged mitochon-
dria and protein aggregates, excessive autophagy under
pathologic conditions can lead to organ dysfunction by
degrading essential proteins and organelles [6].
MicroRNAs (miRNAs) are small, noncoding, regulatory
RNAs composed of 19–22 nucleotides [12]. miRNAs can
act post-transcriptionally to either target specific mRNAs
for degradation or suppress their translation [12, 13].
Consequently, miRNAs play critical roles in the regulation
of multiple biological processes, including development,
organogenesis, cell proliferation, cell differentiation, and
apoptosis [13]. However, little is known about how
miRNAs regulate cell survival. Recent studies have suc-
cessfully established a functional link between cell survival
and a discrete group of survival-regulating miRNAs,
including miRNA-1 [14], miRNA-125 [15], miRNA-206
[14], miRNA-210 [16, 17] and miRNA-708 [18]. In
addition, miRNA-210 regulates survival via a positive
feedback loop during hypoxia [16]. Nevertheless, most
studies have focused on cancer cells as a model to study
the mechanisms of hypoxia-regulated miRNAs in their
endeavor to escape death in the ischemic microenviron-
ment of tumors, and the role of miRNAs in the survival of
transplanted MSCs for therapeutic purposes remains
largely unknown. Therefore, in the present study, we
examined the feasibility of enhancing survival of trans-
planted MSCs by modulating miRNA that targets key
apoptotic molecule caspase-3. We observed that cleaved
(activated) caspase and PARP increased after exposure to
ROS in MSCs. Furthermore, our data showed that let-7b
plays an important role in cell survival, apoptosis, and
autophagy in MSCs under oxidative stress. The results ofour study suggest that miRNA-mediated fortification of
MSCs by enhancing cell survival can be a potential thera-
peutic approach to treat infarcted heart.
Materials and methods
Culture of human MSCs
Human bone marrow-derived mesenchymal stem cells
(hMSCs) were purchased from Lonza (Walkersville, MD,
USA). hMSCs were cultured according to the manufacturer’s
instructions. We used hMSCs at passages 7–10 for experi-
ments, and the cells were cultured in low-glucose Dulbecco's
modified Eagle's medium (DMEM; Life Technologies Cor-
poration, Grand Island, NY, USA) containing 10 % fetal bo-
vine serum (FBS; Life Technologies Corporation).
miRNA mimic transfection
The miRNA mimics, which are synthesized mature miR-
NAs or negative control miRNAs with random sequence
(NC), were purchased from Genolution Pharmaceuticals
(Genolution Inc., Seoul, Korea). Either miRNA mimic or
NC (100 nM each) was transfected into hMSCs using
siLentFect™ Lipid Reagent (Bio-Rad, Hercules, CA, USA)
according to the manufacturer’s instructions. After
4 hours of transfection, the medium was changed to
10 % FBS-containing DMEM with 1 % antibiotics.
Treatment of cells with hydrogen peroxide
The cells were incubated in low-glucose DMEM contain-
ing 10 % FBS. Various concentrations (100–750 μM) of
hydrogen peroxide (H2O2; Sigma, St. Louis, MO, USA)
were then added to the medium and incubated with the
cells for 6 hours.
Cell viability assay
Cell viability was determined using a WST-8 (2-(2-meth-
oxy-4-nitrophenyl)-3-(4-nitrophenyl)-5-(2,4-disulfophe-
nyl)-2H-tetrazolium) assay kit (CCK-8 assay kit; Dojindo,
Kumamoto, Japan). hMSCs were seeded in 96-well plates
(Corning Incorporated, Corning, NY, USA) at a density of
5 × 103 cells per well. The cells were transfected with 100
nM let-7b mimics for 4 hours. After transfection for
4 hours, the medium was changed to fresh 10 % DMEM
and the cells were incubated for 24 hours. After incuba-
tion, cells were treated with varying concentrations of
H2O2 for 6 hours in 10 % DMEM. The cells were then
washed twice with medium, and 100 μl CCK-8 reagent
was added to each well. The samples were subsequently
incubated for 2 hours at 37 °C. The absorbance of the
samples was measured at 450 nm against a background
control using a microplate reader (Bio-Rad).
Real-time PCR
MSCs were plated at a density of 1.5 × 105 cells per well
using six-well plates. The cells were first transfected with
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posed to varying concentrations of H2O2 for 6 hours in
10 % DMEM. Total RNA was prepared using Trizol®
reagent (Sigma). cDNA for real-time PCR was prepared
from purified total RNA using reverse transcriptase
(Taqman® MicroRNA Reverse Transcriptase Kit; Applied
Biosystems, Carlsbad, CA, USA) with specific miRNA
primers. U6 served as a control. The following protocol
was used for amplification: 95 °C for 10 minutes,
followed by 40 cycles of 95 °C for 15 seconds and 60 °C
for 60 seconds. The sequence of the human origin let-7b
(hsa-let-7b) primer was 5′-UUG GUG UGU UGG AUG
AUG GAG U-3′.
For detecting autophagy-related genes, cDNA was
synthesized using a Reverse Transcription System (Pro-
mega Corporation, Fitchburg, WI, USA) according to
the manufacturer’s instructions. One microgram of
RNA was reverse-transcribed in a 20 μl reaction (5 mM
MgCl2, 10 mM Tris–HCl (pH 9.0 at 25 °C), 50 mM
KCl, 0.1 % Triton X-100, 1 mM dNTP, 20 U RNase in-
hibitor, 0.5 μg oligo(dT) primer, and 10 U reverse tran-
scriptase) for 15 minutes at 42 °C, and then ended at
99 °C for 5 minutes. PCR primers were synthesized by
Bioneer Corporation (Daejeon, Korea), and the primers
used were as follows: GAPDH, 5′-CAT GGG TGT GAA
CCA TGA GAA-3′ and 5′-GGT CAT GAG TCC TTC
CAC GAT-3′ (133 base pairs (bp)); autophagy-related
(ATG)5, 5′-AGC AAC TCT GGA TGG GAT TG-3′ and
5′-AGG TCT TTC AGT CGT TGT CTG-3′ (139 bp);
ATG7, 5′-TTT TGC TAT CCT GCC CTC TG-3′ and ′5-
GCT GTG ACT CCT TCT GTT TGAC-3′ (142 bp);
ATG12, 5′-ACC ATC CAA GGA CTC ATT GAC-3′ and
5′-CCA TCA CTG CCA AAA CAC TC-3′ (142 bp); and
beclin 1, 5′-AAG AGG TTG AGA AAG GCG AG-3′ and
5′-TGG GTT TTG ATG GAA TAG GAG C-3′ (111 bp).
PCR reactions were run on a LightCycler 480 SYBR Green
I Master (Roche, Penzberg, Germany) protocol. PCR con-
ditions were set to 95 °C for 3 minutes; 95 °C for 30 sec-
onds with 40 cycles of denaturation; 55 °C for 30 seconds;
72 °C for 90 seconds; and 72 °C for 10 minutes as the final
extension. The threshold cycle (Ct) of each target gene,
which was located in the linear amplification phase of the
PCR, was measured automatically and normalized to the
cycle number of control (U6 and GAPDH for miRNAs
and mRNAs, respectively). The relative expression levels
of each miRNA or mRNA were measured (ΔΔCt) and re-
ported as fold induction (2ΔΔCt).
Western blotting analysis
hMSCs were plated at a density of 3 × 105 per 60 mm
dish. The cells were first transfected with 100 nM let-7b
mimics as described above, and then exposed to varying
concentrations of H2O2 for 6 hours in 10 % DMEM.
hMSCs were lysed in 1× lysis buffer (Cell SignalingTechnology, Beverly, MA, USA) with protease inhibitor
(Roche, Basel, Switzerland) and phosphatase inhibitor
cocktail (Roche) at 4 °C for 25 minutes. The protein con-
centrations were determined using a BCA assay (Pierce
Biotechnology, Rockford, IL, USA). Equal amount of pro-
teins were subjected to 8 or 10 % SDS-PAGE. Proteins
were transferred to polyvinylidene difluoride membranes
(PVDF; Millipore, Billerica, MA, USA) at 100 V and
135 mA for 100 minutes. The membranes were blocked
with Tris-buffered saline–0.1 % Tween 20 (TBS-T; both
Sigma) and 10 % skim milk (BD Science, San Jose, CA,
USA) for 1 hour at room temperature or overnight at
4 °C. The blots were then incubated with primary anti-
PARP, anti-caspase-3, anti-phospho-mitogen-activated
protein kinase (MEK), anti-MEK, anti-p-extracellular
signal regulated kinase (ERK), anti-ERK, anti-Bcl-2,
anti-Bax, anti-light chain 3 A/B (LC3A/B), and anti-β-
actin antibodies for 1 hour at room temperature or
overnight at 4 °C. Polyclonal anti-phospho-MEK, anti-
MEK, anti-ERK, anti-LC-3IIA/B, and anti-PARP anti-
bodies were obtained from Cell Signaling Technology.
Monoclonal anti-phospho-ERK and monoclonal anti-
Bcl2 antibodies were obtained from Santa Cruz Bio-
technology (Santa Cruz, CA, USA), polyclonal anti-Bax
antibody was obtained from Enzo Life Sciences (Ann
Arbor, MI, USA), polyclonal anti-caspase-3 antibody was
obtained from Millipore, and β-actin antibody was ob-
tained from Sigma. All antibodies were diluted 1:1000
with TBS-T and 5 % nonfat dried milk. The membranes
were then washed three times in 1× TBS-T at room
temperature and incubated with a horseradish peroxidase-
conjugated rabbit or mouse secondary antibody (Santa
Cruz Biotechnology). After washing the membrane six
times, immunoreactive proteins were detected using an
ECL system (Amersham Biosciences, Tokyo, Japan). The
images were quantified using ImageJ software.
Annexin V/propidium iodide staining
hMSCs were cultured in four-well culture dishes (1 ×
104 cells per well; Corning Incorporated). The cells were
treated with 500 μM H2O2 for 6 hours with or without
prior let-7b transfection. After 6 hours of H2O2 treat-
ment, the cells were washed with ice-cold phosphate-
buffered saline (PBS; Life Technologies Corporation) for
5 minutes and fixed with 4 % formalin (Sigma) for 10 mi-
nutes. After blocking with 500 μl Annexin-binding buf-
fer, the cells were stained with Annexin V-fluorescein
isothiocyanate (FITC) at room temperature in the dark
for 15 minutes. The dishes were washed with ice-cold
PBS, stained with propidium iodide Annexin V/PI stain-
ing (PI), and diluted with Annexin-binding buffer at
room temperature in the dark for 5 minutes. All images
of Annexin V/PI-positive cells were detected by laser
scanning confocal microscopy (LSM 700; Carl Zeiss,
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Measurement of caspase-3 activity
Relative caspase-3 activity was determined using a caspase-
3 activity assay kit (Roche). In brief, the cultured MSCs (2
× 106) were lysed in 1× DTT (USB Corporation, Cleveland,
OH, USA) for 1 minute. Lysates were collected and loaded
onto a plate coated with monoclonal caspase-3 antibody.
Upon substrate cleavage, free fluorescent AFC (7-amino-4-




A terminal deoxynucleotidyltransferase-mediated dUTP
nick-end labeling (TUNEL) assay was performed accord-
ing to the manufacturer’s instructions (Millipore). hMSCs
were plated in a four-well culture dish (1 × 104 cells per
well) and treated with 500 μM H2O2 for 6 hours with or
without prior let-7b transfection. After the slides were
rinsed with PBS, the cells were fixed with 10 % formalde-
hyde (Sigma) for 10 minutes. The slides were treated with
3.0 % H2O2 and TdT enzyme for 1 hour followed by
digoxygenin-conjugated nucleotide substrate at 37 °C for
30 minutes. Nuclei were stained with 3,3′-diaminobenzi-
dine (DAB; Vector Laboratories, Burlingame, CA, USA)
for 5 minutes, and the slides were counterstained with
methyl green (Sigma). Dark-brown-stained nuclei indi-
cated apoptotic cells. The slides were observed by a virtual
microscopy (BX51/dot Slide; Olympus, Tokyo, Japan).
Luciferase assay
The miRNAs targeting caspase-3 were screened based on
the TargetScan miRNA-target prediction database [19].
We amplified the 959 base pair 3′ untranslated region
(UTR) of human caspase-3, which contains the binding
sites for seven different candidate miRNAs, and the 3′
UTR of human caspase-3 was cloned into the pmirGLO
vector (Promega Corporation, Fitchburg, WI, USA). HeLa
cells (ATCC, Rockville, MD, USA) were plated in 24-well
plates (Corning Incorporated) at a density of 2 × 104 cells
per well. The pmirGLO vector containing the 3′ UTR of
caspase-3 was co-transfected with let-7b mimic or NC
using siLentFect™ (Bio-Rad). Luciferase activity was mea-
sured 48 hours later using a luminometer and the Dual
Luciferase Assay (Promega Corporation) according to the
manufacturer's instructions. Renilla luciferase was used to
normalize the cell number and transfection efficiency.
Design of a miRNA-detecting molecular beacon
We have previously developed a molecular beacon (MB)
to detect miRNA expression in single cells [20]. MBs are
oligonucleotide hybridization probes that indicate thepresence of specific nucleic acids. We designed a MB to
detect the presence of let-7b, which forms a partially
double-stranded structure with a longer Cy3 modified se-
quence (5′-AAC CAC ACA ACC TAC TAC CTC A-3′-
Cy3) and a black hole quencher dye 1 (BHQ1) modified
shorter sequence (3′-TGATGG AGT-5′-BHQ1). The lon-
ger sequence of the MB was designed to complementarily
match the sequence of let-7b (5′-TGA GGT AGT AGG
TTG TGT GGT T-3′) so that when MB and let-7b bind
to each other, making the fluorophore and the quencher
sufficiently separated, fluorescence from the fluorophore
can be detected. These oligonucleotides used for the MB
were manufactured by Bioneer Corporation. To find the
working concentration of the MB, we conducted an in-
vitro assay. Varying concentrations of MB (0, 1, 5, 10, 20,
50, and 100 pM) were reacted with 100 nM let-7b mimic
in Eppendorf tubes for 1 hour at 37 °C, and the fluores-
cence intensity of each group was measured (Varioskan
Flash; Thermo Scientific, Waltham, MA, USA). miRNA-
23 has a completely irrelevant sequence to the let-7b, and
thus a MB designed to detect miR-23 served as a NC.
Since a denatured MB should emit fluorescence, boiled
MB (at 95 °C for 10 minutes) served as a positive control.
Detection of let-7b using a MB
hMSCs were seeded onto 24-well plates at a density of 2
× 104 cells per well. After transfection of 100 nM let-7b
mimic, the cells were incubated with or without 500 μM
H2O2. To detect cellular let-7b, the cells were transfected
with 50 pM MB. The fluorescence intensity was measured
(Varioskan Flash; Thermo Scientific).
I/R injury and transplantation of MSCs
I/R injury was induced in male Sprague–Dawley rats
(250 ± 30 g; Coretech, Pyeongtaek, Korea) by surgical
occlusion of the left anterior descending coronary artery
according to previously described procedures [21]. For
transplantation, 1 × 106 cells were suspended in 30 μl
PBS and injected from the injured region to the border
using a Hamilton syringe with a 30-gauge needle.
Throughout the operation, the animals were ventilated
with 95 % O2 and 5 % CO2 using a Harvard ventilator
(Harvard Apparatus, Holliston, MA, USA). Five animals
per group (ligation, NC-MSCs, let-7b-MSCs) were used
for morphological and functional analysis.
Left ventricular catheterization for hemodynamic analysis
Left ventricular catheterization was performed 3 weeks
after infarction to assess hemodynamics. A Millar Mikro-
tip 2 F pressure-volume transducer (model SPR-838;
Millar Instruments, Houston, TX, USA) was introduced
into the left ventricle via the right carotid artery under
anesthesia. All data were analyzed offline with PVAN 3.5
software (Millar Instruments).
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Heart tissues were fixed in 3.7 % buffered formaldehyde
and embedded in paraffin. Tissue sections (5 μm thick-
ness) were deparaffinized, dehydrated, and rinsed with
PBS. Fibrosis was analyzed by Masson’s trichrome stain-
ing kit (Sigma). Antigen retrieval was performed with
10 mM sodium citrate (pH 6.0; Sigma) in a microwave
for 10 minutes. The sections were incubated in 3 %
H2O2 to quench endogenous peroxidase activity. The
samples were blocked in 2.5 % normal horse serum
(Sigma) and subsequently incubated with antibodies in-
cluding anti-mouse CD31 and anti-rabbit caspase-3. All
antibodies were diluted 1:500 with 1.5 % normal horse
serum. All antibodies were obtained from Santa Cruz
Biotechnology. FITC-conjugated goat anti-mouse IgG
(Jackson ImmunoResearch Laboratories, West Grove, PA,
USA) and rhodamine-conjugated goat anti-rabbit IgG
(Jackson ImmunoResearch Laboratories) were used as
secondary antibodies. All images of CD31 and caspase-3
were obtained using laser scanning confocal microscopy
(LSM 710; Carl Zeiss, Thornwood, NY, USA) and trans-
ferred to a computer equipped with Zen Light Edition
(Zeiss) for analysis. The areas are expressed as percentages
of the total left ventricle. Fibrosis was also analyzed by
Masson’s trichrome staining.Fig. 1 H2O2-induced apoptosis. a Cell survival was evaluated after treating
**p <0.001). b Expression of cleaved caspase-3 and PARP was measured by
H2O2 for 6 hours (*p <0.05). c Schematic presentation of miRNA binding sit
target caspase-3 were selected based on the TargetScan miRNA-target pre
selected. d Cell survival was measured in candidate miRNA-transfected hM
transfection. e Effect of H2O2 on endogenous let-7b expression was evalua
deviation of at least three independent experiments. (*p <0.05, and #p <0.0Experimental ethics policy
All experimental procedures for animal studies were
approved by the Committee for the Care and Use of
Laboratory Animals at Yonsei University College of
Medicine and were performed in accordance with the
Committee’s Guidelines and Regulations for Animal Care.Statistical analysis
Data are expressed as the mean ± standard error of the
mean of at least three independent experiments. Compari-
sons between more than two groups were performed by
one-way analysis of variance using Bonferroni’s correction.
P value of less than 0.05 was considered significant.Results
H2O2-induced apoptosis of hMSCs
We used H2O2 to simulate ROS-mediated cell death in
our experiments. To induce apoptosis, hMSCs were
treated with varying concentrations of H2O2. After 6 hours
of treatment, cell survival significantly decreased when the
concentration of H2O2 was higher than 500 μM (Fig. 1a).
Especially with 500 μM H2O2 treatment, the amount of
both cleaved caspase-3 and PARP also increased (Fig. 1b),cells with increasing concentrations of H2O2 for 6 hours (***p <0.0001,
western blotting in cells treated with increasing concentrations of
e in the 3′ UTR of human caspase-3. Candidate miRNAs predicted to
diction database [19]. miRNAs with an aggregation Pct value ≥0.2 were
SCs. All samples were treated with 500 μM H2O2 after miRNA
ted by real-time PCR. Quantitative data expressed as mean ± standard
5)
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duced apoptosis hMSCs.
Screening of candidate miRNAs targeting caspase-3
To examine whether miRNA-mediated downregulation
of caspase-3 can prevent H2O2-mediated apoptosis, we
first searched miRNAs using the TargetScan, miRNA
target prediction program [19]. Six candidate miRNAs
that are predicted to target caspase-3 (let-7, miR-138,
miR-30b, miR-129, miR-203, and miR-219-5p) and have
an aggregate Pct greater than 0.2 were selected (Fig. 1c).
To empirically validate caspase-3 targeting of those se-
lected miRNAs, the cells were first transfected with each
candidate miRNA, and then miRNA transfected cells
were exposed to 500 μM of H2O2 for 6 hours. The cell
survival data after miRNA transfection and H2O2 treat-
ment indicated that let-7b significantly attenuated cell
survival after H2O2 exposure, while other candidate
miRNA had no significant effect on cell survival (Fig. 1d).
These data suggest that let-7b may exert anti-apoptotic ef-
fect. Additionally, H2O2 treatment significantly decreased
the expression of endogenous let-7b at high concentra-
tions (500 and 750 μM) (Fig. 1e), further suggesting that
decreased let-7b from H2O2 treatment may be linked to
the decreased cell survival after given concentrations of
H2O2 treatment.
Inhibition of caspase-3 by let-7b
Sequence alignment indicated that let-7b recognizes and
binds to the sequence between 1069 and 1900 of the
caspase-3 3′ UTR (Fig. 2a). When the cells were trans-
fected with 100nM let-7b mimics, the amount of cellular
let-7b detected by real-time PCR increased approximately
40-fold compared with nontransfected cells (Fig. 2b).
Transfection of let-7b mimics significantly decreased the
expression of caspase-3 (Fig. 2c) and the luciferase activity
of cells transfected with luciferase vector containing the 3′
UTR of human caspase-3 (Fig. 2d), indicating that let-7b
directly targeted caspase-3.
Visual detection of let-7b in vitro using a MB
We utilized MBs to detect intracellular let-7b. MBs are
oligonucleotide hybridization probes that indicate the
presence of specific nucleic acids. The Cy3-modified
longer sequence of the MB complementarily matches
the sequence of let-7b, so that when let-7b binds to the
MB it disturbs fluorophore (Cy3)–quencher (BHQ1)
interaction producing fluorescence (Fig. 2e). To deter-
mine the optimal amount of MB for detecting let-7b,
we conducted an in-vitro assay using 100 nM let-7b
mimics and increasing concentrations of MB designed
to detect let-7b (1–100 pM), and the result indicated
that 50pM MB produced the most strong fluorescent
signal (Fig. 2f ). Additionally, the negative control group(100 pM MB designed to detect miR-23 was used in-
stead of MB for let-7b) did not produce significant
fluorescence with the presence of let-7b mimic, sug-
gesting the MB for let-7b was indeed specific for de-
tecting let-7b. Since denatured MB should emit
fluorescence, boiled MB (at 95 °C for 10 minutes)
served as a positive control.Anti-apoptotic effect of let-7b on H2O2-treated MSCs
When the cells were treated with 500 μM H2O2, the ex-
pression of caspase-3 increased while let-7b expression
decreased. However, such an increase of caspase-3 and
decrease of let-7b were attenuated by let-7b transfection
prior to H2O2 treatment (Fig. 3a). To determine the ef-
fect of let-7b on survival-related signaling, we examined
the phosphorylation of MEK and ERK and the expres-
sion of anti-apoptotic protein Bcl-2. H2O2 decreased
phosphorylation of both MEK and ERK and the expres-
sion of Bcl-2. However, this H2O2-induced decrease was
attenuated by let-7b transfection prior to H2O2 treat-
ment (Fig. 3b). Furthermore, increased caspase-3 activity
by H2O2 treatment was also attenuated by let-7b trans-
fection (Fig. 3c), and cell survival was also recovered by
let-7b transfection (Fig. 3d), indicating that let-7b-
mediated downregulation of caspase-3 attenuated H2O2-
induced cell death. To further validate the anti-apoptotic
effect of let-7b, Annexin V/PI staining and TUNEL as-
says were performed on H2O2-treated cells with or with-
out let-7b transfection prior to H2O2 treatment.
Annexin V/PI staining indicated that H2O2 increased
both Annexin V and PI staining of MSCs showing in-
creased apoptosis, but this was attenuated by let-7b
transfection prior to H2O2 treatment (Fig. 3e). Further-
more, the number of TUNEL-positive apoptotic cells in-
creased by H2O2 treatment, but such an increase was
suppressed by let-7b transfection (Fig. 3f ), suggesting
that the delivery of exogenous let-7b effectively pre-
vented H2O2-induced apoptosis of MSCs. Previous stud-
ies have demonstrated that miRNAs were involved in
the regulation of autophagic pathway in various cell
types [22, 23]. Thus, we also examined the effect of let-
7b on autophagy-related genes. H2O2 treatment in-
creased the expression of LC3A/B, indicating activation
of autophagic pathway. However, such an increase of au-
tophagic activity was attenuated by let-7b transfection
prior to H2O2 treatment, and this was confirmed by
both immunocytochemistry (Fig. 3g) and western blot
(Fig. 3h). Additionally, the expression of autophagy-
related genes, such as ATG5, ATG7, ATG12, and
BECN1, was attenuated in the MSCs transfected with
let-7b (Fig. 3i). These results indicated that let-7b regu-
lates the expression of autophagy-related genes at both
the mRNA and protein levels.
Fig. 2 Effect of let-7b on the expression of caspase-3 and design of a molecular beacon (MB) for detecting let-7b. a Schematics showing the
let-7b binding site in the 3′ UTR of human caspase-3. b Efficiency of let-7b transfection was measured by real-time PCR (*p <0.05). c Caspase-3
expression with or without let-7b transfection prior to H2O2 treatment was detected by western blotting (*p <0.05). d Let-7b targeting of
caspase-3 was evaluated by a luciferase assay using luciferase vector containing the 3′ UTR of human caspase-3. HeLa cells were transfected with
control vector or vector containing the 3′ UTR of human caspase-3 along with negative control miRNA (NC) or let-7b mimics (100 nM each)
(*p <0.05). e Schematics showing the working principle of a MB designed to detect let-7b. f Working concentration of the MB was determined by
an in-vitro assay using 100 nM let-7b and increasing concentrations of MB designed to detect let-7b. MB designed to detect miR-23 served
as NC and denatured MB (Den MB) served as a positive control (*p <0.05). Quantitative data expressed as mean ± standard deviation of at least
three independent experiments
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ischemic injury
To examine the therapeutic potential of let-7b-enriched
MSCs in ischemic myocardium, we transplanted let-7b-
enriched MSCs into ischemic rat hearts. The area of
fibrosis significantly decreased in the hearts transplanted
with let-7b-enriched MSCs (let-7b-MSCs) compared
with those of untreated ischemic hearts or the hearts
transplanted with negative control miRNA-enriched
MSCs (NC-MSCs) (Fig. 4a). To assess the survival of
transplanted MSCs, we stained the cells with 4′,6-diami-
dino-2-phenylindole (DAPI) prior to transplantation.
The number of DAPI-positive cells was counted 3 daysafter the transplantation, and the results indicated that
the number of DAPI-stained cells increased in the let-
7b-MSC transplanted heart compared with the NC-MSC
transplanted heart (Fig. 4b). The result of immuno-
histochemistry using endothelial cell marker CD31
indicated that the transplantation of let-7b-enriched
MSCs increased the number of CD31-positive cells per
field in infarcted myocardium compared with NC-MSC
transplanted heart (Fig. 4c), while the number of caspase-
3-positive cells decreased in this group (Fig. 4d), indicating
that the transplantation of let-7b-enriched MSCs effect-
ively prevented apoptosis but enhanced angiogenesis in in-
farcted myocardium. Additionally, analysis of cardiac
Fig. 3 (See legend on next page.)
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Fig. 3 let-7b upregulates survival signaling but downregulates autophagy-related molecules. a Intracellular caspase-3 (green) and let-7b (red)
were visualized under confocal microscopy. The cells were either untreated (control), H2O2-treated (H2O2), or transfected with let-7b prior to H2O2
treatment (H2O2 + let-7b). Nuclei stained blue. Scale bar = 500 μm. b Various survival-related proteins were detected by western blotting.
(*p <0.05, #p <0.05). c Caspase-3 activity and d cell survival was evaluated. (*p <0.05, #p <0.05 ). e Annexin V (green)/PI (red) staining. f TUNEL
staining. g LC3A/B (green) was detected by confocal microscopy. Nuclei stained blue. Scale bar = 100 μm. h Expression of LC3A/B was detected
by western blotting (*p <0.05, #p <0.05). i Expression of autophagy-related genes was evaluated by real-time PCR (**p <0.001, *p <0.05, #p <0.05).
Quantitative data expressed as the mean ± standard deviation of at least three independent experiments
Ham et al. Stem Cell Research & Therapy  (2015) 6:147 Page 9 of 11function indicated that the transplantation of let-7b-
enriched MSC improved functional parameters such as
stroke volumes, end-diastolic volumes, end-systolic vol-
umes, stroke work, stroke volume, and ejection fraction
compared with other groups (Table 1). Taken together,
these data suggest that the let-7b-mediated downregu-
lation of caspase-3 is a viable therapeutic strategy for
the treatment of ischemic myocardium.
Discussion
MSCs have been used in cell-based therapy for cardiac
repair and they are amenable to various pretransplant
treatments including cytokines and growth factors, pre-
conditioning, and genetic modification [24]. However,
low cell survival after transplantation caused by apop-
tosis of injected cells due to the loss of matrix attach-
ment in the infarcted region remains a major problemFig. 4 Let-7b-MSCs improved ischemic heart function. a Fibrosis area was
the transplanted cells, cells were stained with DAPI prior to transplantation
counted (*p <0.05). c Angiogenesis was evaluated by CD31 (green, arrow)
Scale bar = 50 μm. Quantitative data expressed as the mean ± standard de[25]. Consequently, inhibition of apoptosis has long been
emphasized in the treatment of heart disease. Apoptosis
contributes to the pathogenesis of I/R injury, and
apoptosis-related caspase family molecules play import-
ant roles in the progression of heart disease [26]. In
myocardial infarction, Ca2+ overload and ROS can in-
duce apoptosis in the ischemic area [27]. In addition,
several studies have reported that autophagy is upregu-
lated in the injured heart [6, 27]. However, it is still un-
clear whether autophagy plays a protective or
detrimental role in the damaged heart. For example, au-
tophagy during energy starvation under mild ischemic
conditions delayed irreversible cell injuries, including
apoptosis and necrosis [28], while autophagy under
harsh conditions, such as I/R which we simulated using
an animal model for this study, contributed to cell death
via the generation of ROS [27, 29]. Additionally, severaldetermined using Masson’s trichrome staining (**p <0.001). b To track
. Three days after transplantation, the number of DAPI stained cells was
staining. d Caspase-3 (red, arrow) was stained as a marker of apoptosis.
viation of at least three independent experiments
Table 1 Effect of let-7b-MSCs on cardiac function in ischemia/reperfusion animal model
Control I/R I/R + MSCs I/R + let-7b-MSCs
EF (%) 69.68 ± 1.48 40.96 ± 2.42 53.4 ± 0.92* 65.29 ± 1.15**
ESV (μl) 62.67 ± 1.82 120.96 ± 1.95 87.85 ± 1.95* 74.52 ± 1.25**
EDV (μl) 124.43 ± 1.06 189.49 ± 1.95 149.48 ± 2.17* 135.93 ± 2.00*
CO (μl/minute) 37 675.1 ± 2584.66 16 335.9 ± 925.71 24 154.9 ± 589.04 28 580 ± 500.51*
SW (mmHg* μl) 12 710 ± 896 6335 ± 475 10 245 ± 350* 12 526 ± 442*
SV (μl) 156.91 ± 10.57 76.9 ± 5.79 110.14 ± 7.09* 112.68 ± 1.69*
All values expressed as mean ± standard error of the mean
*p <0.05 vs. I/R group
**p <0.001 vs. I/R group
CO cardiac output, EDV end-diastolic volume, EF ejection fraction, ESV end-systolic volume, I/R ischemia/reperfusion, MSC mesenchymal stem cell, SV stroke
volume, SW 1:13 stroke work
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apoptosis and autophagy exists [30]. The Atg4 family
member Atg4D is cleaved by caspase-3, and the expres-
sion of beclin-1 regulates the expression of caspase-9
[31, 32]. In the present study, ROS increased the ex-
pressions of autophagy-related genes, including Atg5,
Atg7, Atg12, and beclin-1, as well as the autophagy
marker LC3A/B. However, such ROS-induced increase
of autophage-related gene expressions was attenuated
by let-7b transfection, and this may have attributed to
the increased survival of let-7b transfected cells.
Recently, several studies have demonstrated great po-
tential of miRNAs as a new therapeutic means for ische-
mic heart disease. A number of miRNAs have been
reported to target caspase-3. miR-378 has been reported
to attenuate apoptosis of cardiomyocytes by targeting
caspase-3 [33]. Furthermore, members of the let-7 famil-
y—namely let-7a, let-7e, and let-7 g—have also been re-
ported to target caspase-3 in cancer cells, PC12 cells,
and endothelial cells, respectively [26, 34, 35]. Aside
from the miRNAs that are not members of the let-7
family, the predicted binding sequence of let-7 family
members (a, b, c, d, e, f, g, and i) to the 3′ UTR of hu-
man caspase-3 is identical. The only difference was that
let-7b had a lower context-positive score (−0.40 for let-
7b vs. –0.39 or −0.38 for other members). Since we did
not examine the effect of other let-7 family members on
caspase-3 expression in the present study, it is difficult
to draw any conclusion on the specificity of let-7b in
MSCs. This is one of the limitations of the present
study, and specific roles of individual let-7 family mem-
bers on the cell survival, especially of MSCs, will be an
interesting subject of further study. Although additional
studies are required to further elucidate the underlying
mechanisms, our study also demonstrated that modula-
tion of caspase-3 using let-7b can be an effective means
to enhance post-transplantation survival of MSCs and
subsequent functional recovery of the damaged heart by
upregulating survival signals such as MEK and ERK,
while suppressing apoptotic signaling activation.Conclusions
We have provided an effective strategy for enhancing cell
survival after transplantation. Our study indicates that the
regulation of caspase-3 by let-7b can improve survival of
hMSCs via the modulation of survival signaling and
autophagy-related genes. This finding suggests that the
compensation of let-7b prior to cell transplantation can be
a therapeutically sound approach for treating ischemic
hearts.
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